Skip to content
10-Q

Quarterly Report

Applied BioSciences Corp.

0001477932-19-000451

← back to feed
Filed
Feb 13, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Feb 8, 2019 13.34M sh
Current Liabilities Q3 2019 · Dec 31, 2018 $183.38K
Current Liabilities Q3 2019 · Mar 31, 2018 $35.89K
Current Assets Q3 2019 · Dec 31, 2018 $376.25K
Current Assets Q3 2019 · Mar 31, 2018 $226.85K
Total Assets Q3 2019 · Dec 31, 2018 $1.81M
Total Assets Q3 2019 · Mar 31, 2018 $705.33K
Net Income Q3 2019 · Sep 30, 2018 −$113.76K
Net Income Q3 2019 · Jun 30, 2018 −$401.76K
Net Income Q3 2019 · Dec 31, 2017 −$342.86K
Net Income Q3 2019 · Dec 31, 2017 −$717.47K
Net Income Q3 2019 · Sep 30, 2017 −$177.41K
Net Income Q3 2019 · Jun 30, 2017 −$197.2K
Capex Q3 2019 · Dec 31, 2017 $1.57K
Operating Cash Flow Q3 2019 · Dec 31, 2017 −$420.7K
Sga Expense Q3 2019 · Dec 31, 2017 $133.98K
Sga Expense Q3 2019 · Dec 31, 2017 $358.19K
Operating Income Q3 2019 · Dec 31, 2017 −$342.86K
Operating Income Q3 2019 · Dec 31, 2017 −$717.47K
Gross Profit Q3 2019 · Dec 31, 2017 $12.61K
Gross Profit Q3 2019 · Dec 31, 2017 $38.83K
Cost Of Revenue Q3 2019 · Dec 31, 2017 $50.37K
Cost Of Revenue Q3 2019 · Dec 31, 2017 $140.71K
Revenue Q3 2019 · Dec 31, 2017 $62.98K
Revenue Q3 2019 · Dec 31, 2017 $179.53K